N3T-040245

N/A

Report date: 2025/03/11 09:55:27
NME

Base Information

Drug NameN3T-040245
Drug Alias NameN3T-040245N3T040245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 agonistsPotassium voltage-gated channel subfamily KQT member 3 activators
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsAmyotrophic Lateral SclerosisEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNeuroThree Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroThree Therapeutics IncJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A